Article Information
History
- November 6, 2022.
Article Versions
- Version 1 (July 17, 2022 - 09:00).
- Version 2 (August 23, 2022 - 08:37).
- Version 3 (August 24, 2022 - 10:55).
- Version 4 (August 25, 2022 - 06:24).
- You are viewing Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Xueming Yao1,
- Hongxi Yang2,a,
- Han Han1,
- Xuejing Kou1,
- Yuhan Jiang3,
- Menghan Luo3,
- Yao Zhou3,
- Jianhua Wang3,
- Xutong Fan3,
- Xiaohong Wang2,*,
- Mulin Jun Li2,3,* and
- Hua Yan1,4,5,*
- 1Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, 300052, China
- 2Department of Pharmacology, Tianjin Key Laboratory of Inflammation Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China
- 3Department of Bioinformatics, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China
- 4Laboratory of Molecular Ophthalmology, Tianjin Medical University, Tianjin, 300070, China
- 5School of Medicine, Nankai University, Tianjin, 300071, China
- ↵*Correspondence: xiaohongwang{at}tmu.edu.cn (X.W.), mulin{at}tmu.edu.cn (M.J.L.), zyyyanhua{at}tmu.edu.cn (H.Y.)
↵a X.Y. and H.Y. contributed equally.